San Diego Padres shortstop Fernando Tatis Jr. was suspended 80 games Friday for violating Major League Baseball's performance-enhancing drug policy, and now, general manager A.J. Preller is questioning the slugger's maturity.

"I think we're hoping that from the offseason to now, that there would be some maturity. And obviously with the news today, it's more of a pattern and something we've got to dig a little bit more into," Preller told reporters. "I'm sure he's very disappointed but at the end of the day, it's one thing to say it. You have to start by showing it with your actions."

"I think what we need to get to is a point in time we trust [him]. Over the course of the last six or seven months, that's been something that we haven't been really able to have there," Preller added, via ESPN's Jeff Passan.

"I think from our standpoint, obviously he's a great talent, he's a guy we have a lot of history with and do believe in, but these things only work when there's trust both ways.''

Tatis tested positive for the performance-enhancing drug Clostebol, according to Passan. He will miss the remainder of the 2022 season and will miss the beginning of the 2023 campaign while serving the suspension.

The 2021 All-Star also will not be allowed to compete for the Dominican Republic at the 2023 World Baseball Classic.